We are live on ! Find out more
MYAM

Meiji Yasuda Asset Management Portfolio holdings

AUM $2B
1-Year Est. Return 22.52%
This Fund
S&P 500
This Quarter Est. Return
+12.33%
1 Year Est. Return
+22.52%
3 Year Est. Return
+72.7%
5 Year Est. Return
+101.01%
10 Year Est. Return
+376.57%
AUM
$1.62B
AUM Growth
+$208M
Cap. Flow
+$56.5M
Cap. Flow %
3.49%
Top 10 Hldgs %
23.27%
Holding
546
New
32
Increased
378
Reduced
121
Closed
11

Top Buys

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$3.98M
2
AMZN icon
Amazon
AMZN
+$3.04M
3
TSLA icon
Tesla
TSLA
+$2.66M
4
UNP icon
Union Pacific
UNP
+$2.66M
5
AAPL icon
Apple
AAPL
+$2.55M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$2.38M
2
CL icon
Colgate-Palmolive
CL
+$2.12M
3
MDT icon
Medtronic
MDT
+$1.61M
4
MRNA icon
Moderna
MRNA
+$1.56M
5
GNRC icon
Generac Holdings
GNRC
+$1.54M

Sector Composition

Rank Sector Weight
1 Technology 24.83%
2 Healthcare 15.39%
3 Financials 11.91%
4 Consumer Discretionary 10.39%
5 Communication Services 9.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DIS icon
26
Walt Disney
DIS
$178B
$12.4M 0.77%
79,936
+1,724
+2% +$278K
ABBV icon
27
AbbVie
ABBV
$438B
$12.2M 0.76%
90,379
-270
-0.3% -$31.9K
CSCO icon
28
Cisco
CSCO
$483B
$12.2M 0.76%
193,019
+26,617
+16% +$1.52M
WMT icon
29
Walmart Inc
WMT
$897B
$11.7M 0.72%
241,722
+29,394
+14% +$1.4M
PLD icon
30
Prologis
PLD
$132B
$10.8M 0.67%
64,084
+7,894
+14% +$1.18M
LLY icon
31
Eli Lilly
LLY
$1.1T
$9.96M 0.62%
36,046
-9,387
-21% -$2.38M
MRK icon
32
Merck
MRK
$323B
$9.85M 0.61%
128,555
+2,104
+2% +$168K
BRK.B icon
33
Berkshire Hathaway Class B
BRK.B
$1.13T
$9.69M 0.6%
32,417
+7,203
+29% +$2.06M
KEYS icon
34
Keysight
KEYS
$57.3B
$9.68M 0.6%
46,874
+300
+0.6% +$56.1K
MCD icon
35
McDonald's
MCD
$194B
$9.61M 0.59%
35,844
-142
-0.4% -$35.9K
NKE icon
36
Nike
NKE
$62.5B
$9.51M 0.59%
57,026
-4,193
-7% -$692K
ZTS icon
37
Zoetis
ZTS
$30.9B
$9.44M 0.58%
38,683
+327
+0.9% +$71.6K
AXP icon
38
American Express
AXP
$229B
$9.16M 0.57%
56,022
+129
+0.2% +$22K
AME icon
39
Ametek
AME
$58B
$9.1M 0.56%
61,866
-810
-1% -$111K
SPGI icon
40
S&P Global
SPGI
$121B
$8.98M 0.56%
19,033
+18
+0.1% +$8.23K
ADBE icon
41
Adobe
ADBE
$109B
$8.62M 0.53%
15,208
+357
+2% +$223K
A icon
42
Agilent Technologies
A
$42B
$8.59M 0.53%
53,785
+1,525
+3% +$238K
CMCSA icon
43
Comcast
CMCSA
$89.4B
$8.51M 0.53%
169,128
+76,290
+82% +$3.98M
GILD icon
44
Gilead Sciences
GILD
$165B
$8.46M 0.52%
116,528
+23,255
+25% +$1.6M
ECL icon
45
Ecolab
ECL
$79.7B
$8.27M 0.51%
35,270
+2,015
+6% +$455K
INTC icon
46
Intel
INTC
$492B
$8.26M 0.51%
160,292
+1,236
+0.8% +$63.2K
ETN icon
47
Eaton
ETN
$173B
$7.82M 0.48%
45,229
+139
+0.3% +$23K
SCHW
48
Charles Schwab
SCHW
$187B
$7.81M 0.48%
92,859
+4
+0% +$324
KO icon
49
Coca-Cola
KO
$374B
$7.79M 0.48%
131,476
+738
+0.6% +$41.1K
CCI icon
50
Crown Castle
CCI
$31.3B
$7.72M 0.48%
36,969
+1,080
+3% +$199K
1
2
3 4 5

Similar funds

LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return
C
Consulta London, United Kingdom $2.01B AUM 16.82% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return
AF
Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return

Meiji Yasuda Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Meiji Yasuda Asset Management held 546 positions worth $1.62B, up 15% from $1.41B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Meiji Yasuda Asset Management deployed $56.5M of net new capital in Q4 2021, opening 32 new positions and adding to 378 existing holdings. Its largest new stake was Neurocrine Biosciences: 6,430 shares worth $548K.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $2.38M trimmed.

  • Meiji Yasuda Asset Management's largest Q4 2021 buy was Neurocrine Biosciences: 6,430 shares worth $548K.
  • Meiji Yasuda Asset Management added most to Comcast in Q4 2021, an estimated $3.98M increase.
  • Meiji Yasuda Asset Management's biggest Q4 2021 reduction was Eli Lilly, cutting an estimated $2.38M.
  • Meiji Yasuda Asset Management fully exited News Corp Class A in Q4 2021, selling an estimated $1.2M.
  • Meiji Yasuda Asset Management's ten largest holdings make up 23% of its $1.62B portfolio in Q4 2021.
  • Meiji Yasuda Asset Management opened 32 new positions and closed 11 in Q4 2021.
  • Meiji Yasuda Asset Management's portfolio value rose 15% quarter-over-quarter to $1.62B.

Based on Meiji Yasuda Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.